APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ertapenem Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ertapenem Injection Market Analysis and Forecast 2026-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchErtapenem Injection Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Ertapenem Injection Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Ertapenem Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ertapenem Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Ertapenem Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Ertapenem Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ertapenem Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ertapenem Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ertapenem Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ertapenem Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ertapenem Injection include Merck, Aurobindo Pharma, Endo and ACS Dobfar, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ertapenem Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ertapenem Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Ertapenem Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ertapenem Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ertapenem Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ertapenem Injection sales, projected growth trends, production technology, application and end-user industry.

Ertapenem Injection Segment by Company

Merck

Aurobindo Pharma

Endo

ACS Dobfar

Ertapenem Injection Segment by Type

1g/Vial

Others

Ertapenem Injection Segment by Application

Adult

Pediatric

Ertapenem Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ertapenem Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ertapenem Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ertapenem Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ertapenem Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ertapenem Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ertapenem Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ertapenem Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 1g/Vial Major Manufacturers Table 3. Others Major Manufacturers Table 4. Global Ertapenem Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adult Major Manufacturers Table 6. Pediatric Major Manufacturers Table 7. Ertapenem Injection Industry Trends Table 8. Ertapenem Injection Industry Drivers Table 9. Ertapenem Injection Industry Opportunities and Challenges Table 10. Ertapenem Injection Industry Restraints Table 11. Global Ertapenem Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Ertapenem Injection Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Ertapenem Injection Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Ertapenem Injection Revenue Market Share by Region (2021-2026) Table 15. Global Ertapenem Injection Revenue Market Share by Region (2027-2032) Table 16. Global Ertapenem Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 17. Global Ertapenem Injection Sales by Region (2021-2026) & (W Units) Table 18. Global Ertapenem Injection Sales by Region (2027-2032) & (W Units) Table 19. Global Ertapenem Injection Sales Market Share by Region (2021-2026) Table 20. Global Ertapenem Injection Sales Market Share by Region (2027-2032) Table 21. Global Ertapenem Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Ertapenem Injection Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Ertapenem Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Ertapenem Injection Sales Market Share by Manufacturers (2021-2026) Table 25. Global Ertapenem Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Ertapenem Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Ertapenem Injection Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Ertapenem Injection Manufacturers, Product Type & Application Table 29. Global Ertapenem Injection Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Ertapenem Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Ertapenem Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Ertapenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Ertapenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Ertapenem Injection Revenue Market Share by Type (2021-2026) Table 36. Global Ertapenem Injection Revenue Market Share by Type (2027-2032) Table 37. Global Ertapenem Injection Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 38. Global Ertapenem Injection Sales by Type (2021-2026) & (W Units) Table 39. Global Ertapenem Injection Sales by Type (2027-2032) & (W Units) Table 40. Global Ertapenem Injection Sales Market Share by Type (2021-2026) Table 41. Global Ertapenem Injection Sales Market Share by Type (2027-2032) Table 42. Global Ertapenem Injection Price by Type (2021-2026) & (US$/Unit) Table 43. Global Ertapenem Injection Price by Type (2027-2032) & (US$/Unit) Table 44. Global Ertapenem Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Ertapenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Ertapenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Ertapenem Injection Revenue Market Share by Application (2021-2026) Table 48. Global Ertapenem Injection Revenue Market Share by Application (2027-2032) Table 49. Global Ertapenem Injection Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 50. Global Ertapenem Injection Sales by Application (2021-2026) & (W Units) Table 51. Global Ertapenem Injection Sales by Application (2027-2032) & (W Units) Table 52. Global Ertapenem Injection Sales Market Share by Application (2021-2026) Table 53. Global Ertapenem Injection Sales Market Share by Application (2027-2032) Table 54. Global Ertapenem Injection Price by Application (2021-2026) & (US$/Unit) Table 55. Global Ertapenem Injection Price by Application (2027-2032) & (US$/Unit) Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck Ertapenem Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Merck Ertapenem Injection Product Portfolio Table 60. Merck Recent Development Table 61. Aurobindo Pharma Company Information Table 62. Aurobindo Pharma Business Overview Table 63. Aurobindo Pharma Ertapenem Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Aurobindo Pharma Ertapenem Injection Product Portfolio Table 65. Aurobindo Pharma Recent Development Table 66. Endo Company Information Table 67. Endo Business Overview Table 68. Endo Ertapenem Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Endo Ertapenem Injection Product Portfolio Table 70. Endo Recent Development Table 71. ACS Dobfar Company Information Table 72. ACS Dobfar Business Overview Table 73. ACS Dobfar Ertapenem Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. ACS Dobfar Ertapenem Injection Product Portfolio Table 75. ACS Dobfar Recent Development Table 76. North America Ertapenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Ertapenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Ertapenem Injection Sales by Type (2021-2026) & (W Units) Table 79. North America Ertapenem Injection Sales by Type (2027-2032) & (W Units) Table 80. North America Ertapenem Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 81. North America Ertapenem Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 82. North America Ertapenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Ertapenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Ertapenem Injection Sales by Application (2021-2026) & (W Units) Table 85. North America Ertapenem Injection Sales by Application (2027-2032) & (W Units) Table 86. North America Ertapenem Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 87. North America Ertapenem Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 88. North America Ertapenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Ertapenem Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Ertapenem Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Ertapenem Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 92. North America Ertapenem Injection Sales by Country (2021-2026) & (W Units) Table 93. North America Ertapenem Injection Sales by Country (2027-2032) & (W Units) Table 94. North America Ertapenem Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 95. North America Ertapenem Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 96. United States Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 97. Canada Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 98. Europe Ertapenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Ertapenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Ertapenem Injection Sales by Type (2021-2026) & (W Units) Table 101. Europe Ertapenem Injection Sales by Type (2027-2032) & (W Units) Table 102. Europe Ertapenem Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 103. Europe Ertapenem Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 104. Europe Ertapenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Ertapenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Ertapenem Injection Sales by Application (2021-2026) & (W Units) Table 107. Europe Ertapenem Injection Sales by Application (2027-2032) & (W Units) Table 108. Europe Ertapenem Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 109. Europe Ertapenem Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 110. Europe Ertapenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Ertapenem Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. Europe Ertapenem Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. Europe Ertapenem Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 114. Europe Ertapenem Injection Sales by Country (2021-2026) & (W Units) Table 115. Europe Ertapenem Injection Sales by Country (2027-2032) & (W Units) Table 116. Europe Ertapenem Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 117. Europe Ertapenem Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 118. Germany Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 119. France Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 120. U.K. Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 121. Italy Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 122. Netherlands Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 123. China Ertapenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 124. China Ertapenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 125. China Ertapenem Injection Sales by Type (2021-2026) & (W Units) Table 126. China Ertapenem Injection Sales by Type (2027-2032) & (W Units) Table 127. China Ertapenem Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 128. China Ertapenem Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 129. China Ertapenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 130. China Ertapenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 131. China Ertapenem Injection Sales by Application (2021-2026) & (W Units) Table 132. China Ertapenem Injection Sales by Application (2027-2032) & (W Units) Table 133. China Ertapenem Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 134. China Ertapenem Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 135. Asia Ertapenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Ertapenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Ertapenem Injection Sales by Type (2021-2026) & (W Units) Table 138. Asia Ertapenem Injection Sales by Type (2027-2032) & (W Units) Table 139. Asia Ertapenem Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Asia Ertapenem Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Asia Ertapenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Ertapenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Ertapenem Injection Sales by Application (2021-2026) & (W Units) Table 144. Asia Ertapenem Injection Sales by Application (2027-2032) & (W Units) Table 145. Asia Ertapenem Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Asia Ertapenem Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Ertapenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Ertapenem Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Asia Ertapenem Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Asia Ertapenem Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 151. Asia Ertapenem Injection Sales by Country (2021-2026) & (W Units) Table 152. Asia Ertapenem Injection Sales by Country (2027-2032) & (W Units) Table 153. Asia Ertapenem Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Asia Ertapenem Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Japan Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 156. South Korea Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 157. India Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 158. Australia Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 159. China Taiwan Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 160. Southeast Asia Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 161. SAMEA Ertapenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA Ertapenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA Ertapenem Injection Sales by Type (2021-2026) & (W Units) Table 164. SAMEA Ertapenem Injection Sales by Type (2027-2032) & (W Units) Table 165. SAMEA Ertapenem Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 166. SAMEA Ertapenem Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 167. SAMEA Ertapenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Ertapenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Ertapenem Injection Sales by Application (2021-2026) & (W Units) Table 170. SAMEA Ertapenem Injection Sales by Application (2027-2032) & (W Units) Table 171. SAMEA Ertapenem Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 172. SAMEA Ertapenem Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 173. SAMEA Ertapenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. SAMEA Ertapenem Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. SAMEA Ertapenem Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. SAMEA Ertapenem Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 177. SAMEA Ertapenem Injection Sales by Country (2021-2026) & (W Units) Table 178. SAMEA Ertapenem Injection Sales by Country (2027-2032) & (W Units) Table 179. SAMEA Ertapenem Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 180. SAMEA Ertapenem Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Brazil Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 182. Argentina Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 183. Chile Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 184. Colombia Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 185. Peru Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 186. Saudi Arabia Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 187. Israel Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 188. UAE Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 189. Turkey Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 190. Iran Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 191. Egypt Ertapenem Injection Revenue (2021-2032) & (US$ Million) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Ertapenem Injection Distributors List Table 195. Ertapenem Injection Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Ertapenem Injection Image Figure 2. Global Ertapenem Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ertapenem Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 1g/Vial Image Figure 5. Others Image Figure 6. Global Ertapenem Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ertapenem Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adult Image Figure 9. Pediatric Image Figure 10. Global Ertapenem Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Ertapenem Injection Revenue (2021-2032) & (US$ Million) Figure 12. Global Ertapenem Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Ertapenem Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Ertapenem Injection Revenue Market Share by Region (2021-2032) Figure 15. Global Ertapenem Injection Sales (2021-2032) & (W Units) Figure 16. Global Ertapenem Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 17. Global Ertapenem Injection Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Ertapenem Injection Sales YoY (2021-2032) & (W Units) Figure 19. Europe Ertapenem Injection Sales YoY (2021-2032) & (W Units) Figure 20. China Ertapenem Injection Sales YoY (2021-2032) & (W Units) Figure 21. Asia (Excluding China) Ertapenem Injection Sales YoY (2021-2032) & (W Units) Figure 22. South America, Middle East and Africa Ertapenem Injection Sales YoY (2021-2032) & (W Units) Figure 23. Global Ertapenem Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Ertapenem Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Ertapenem Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Ertapenem Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Ertapenem Injection Revenue Market Share by Type (2021-2032) Figure 29. Global Ertapenem Injection Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 30. Global Ertapenem Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Ertapenem Injection Sales Market Share by Type (2021-2032) Figure 32. Global Ertapenem Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Ertapenem Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Ertapenem Injection Revenue Market Share by Application (2021-2032) Figure 35. Global Ertapenem Injection Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Ertapenem Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Ertapenem Injection Sales Market Share by Application (2021-2032) Figure 38. North America Ertapenem Injection Revenue Share by Type (2021-2032) Figure 39. North America Ertapenem Injection Sales Share by Type (2021-2032) Figure 40. North America Ertapenem Injection Revenue Share by Application (2021-2032) Figure 41. North America Ertapenem Injection Sales Share by Application (2021-2032) Figure 42. North America Ertapenem Injection Revenue Share by Country (2021-2032) Figure 43. North America Ertapenem Injection Sales Share by Country (2021-2032) Figure 44. Europe Ertapenem Injection Revenue Share by Type (2021-2032) Figure 45. Europe Ertapenem Injection Sales Share by Type (2021-2032) Figure 46. Europe Ertapenem Injection Revenue Share by Application (2021-2032) Figure 47. Europe Ertapenem Injection Sales Share by Application (2021-2032) Figure 48. Europe Ertapenem Injection Revenue Share by Country (2021-2032) Figure 49. Europe Ertapenem Injection Sales Share by Country (2021-2032) Figure 50. China Ertapenem Injection Revenue Share by Type (2021-2032) Figure 51. China Ertapenem Injection Sales Share by Type (2021-2032) Figure 52. China Ertapenem Injection Revenue Share by Application (2021-2032) Figure 53. China Ertapenem Injection Sales Share by Application (2021-2032) Figure 54. Asia Ertapenem Injection Revenue Share by Type (2021-2032) Figure 55. Asia Ertapenem Injection Sales Share by Type (2021-2032) Figure 56. Asia Ertapenem Injection Revenue Share by Application (2021-2032) Figure 57. Asia Ertapenem Injection Sales Share by Application (2021-2032) Figure 58. Asia Ertapenem Injection Revenue Share by Country (2021-2032) Figure 59. Asia Ertapenem Injection Sales Share by Country (2021-2032) Figure 60. SAMEA Ertapenem Injection Revenue Share by Type (2021-2032) Figure 61. SAMEA Ertapenem Injection Sales Share by Type (2021-2032) Figure 62. SAMEA Ertapenem Injection Revenue Share by Application (2021-2032) Figure 63. SAMEA Ertapenem Injection Sales Share by Application (2021-2032) Figure 64. SAMEA Ertapenem Injection Revenue Share by Country (2021-2032) Figure 65. SAMEA Ertapenem Injection Sales Share by Country (2021-2032) Figure 66. Ertapenem Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Ertapenem Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1g/Vial
  • Others
Applications
  • Adult
  • Pediatric
Companies covered
  • Merck
  • Aurobindo Pharma
  • Endo
  • ACS Dobfar

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ertapenem Injection Market by Type
  3. 1.2.1 Global Ertapenem Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 1g/Vial
  5. 1.2.3 Others
  6. 1.3 Ertapenem Injection Market by Application
  7. 1.3.1 Global Ertapenem Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adult
  9. 1.3.3 Pediatric
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Ertapenem Injection Market Dynamics
  1. 2.1 Ertapenem Injection Industry Trends
  2. 2.2 Ertapenem Injection Industry Drivers
  3. 2.3 Ertapenem Injection Industry Opportunities and Challenges
  4. 2.4 Ertapenem Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ertapenem Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ertapenem Injection Revenue by Region
  3. 3.2.1 Global Ertapenem Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ertapenem Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Ertapenem Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Ertapenem Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ertapenem Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ertapenem Injection Sales by Region
  9. 3.4.1 Global Ertapenem Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ertapenem Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Ertapenem Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Ertapenem Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ertapenem Injection Revenue by Manufacturers
  2. 4.1.1 Global Ertapenem Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ertapenem Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ertapenem Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ertapenem Injection Sales by Manufacturers
  6. 4.2.1 Global Ertapenem Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ertapenem Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ertapenem Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ertapenem Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ertapenem Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ertapenem Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ertapenem Injection Manufacturers, Product Type & Application
  13. 4.7 Global Ertapenem Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ertapenem Injection Market CR5 and HHI
  16. 4.8.2 2025 Ertapenem Injection Tier 1, Tier 2, and Tier 3
5 Ertapenem Injection Market by Type
  1. 5.1 Global Ertapenem Injection Revenue by Type
  2. 5.1.1 Global Ertapenem Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ertapenem Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ertapenem Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ertapenem Injection Sales by Type
  6. 5.2.1 Global Ertapenem Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ertapenem Injection Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Ertapenem Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ertapenem Injection Price by Type
6 Ertapenem Injection Market by Application
  1. 6.1 Global Ertapenem Injection Revenue by Application
  2. 6.1.1 Global Ertapenem Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ertapenem Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ertapenem Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ertapenem Injection Sales by Application
  6. 6.2.1 Global Ertapenem Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ertapenem Injection Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Ertapenem Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ertapenem Injection Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Ertapenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Ertapenem Injection Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Aurobindo Pharma
  8. 7.2.1 Aurobindo Pharma Company Information
  9. 7.2.2 Aurobindo Pharma Business Overview
  10. 7.2.3 Aurobindo Pharma Ertapenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aurobindo Pharma Ertapenem Injection Product Portfolio
  12. 7.2.5 Aurobindo Pharma Recent Developments
  13. 7.3 Endo
  14. 7.3.1 Endo Company Information
  15. 7.3.2 Endo Business Overview
  16. 7.3.3 Endo Ertapenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Endo Ertapenem Injection Product Portfolio
  18. 7.3.5 Endo Recent Developments
  19. 7.4 ACS Dobfar
  20. 7.4.1 ACS Dobfar Company Information
  21. 7.4.2 ACS Dobfar Business Overview
  22. 7.4.3 ACS Dobfar Ertapenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 ACS Dobfar Ertapenem Injection Product Portfolio
  24. 7.4.5 ACS Dobfar Recent Developments
8 North America
  1. 8.1 North America Ertapenem Injection Market Size by Type
  2. 8.1.1 North America Ertapenem Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Ertapenem Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Ertapenem Injection Price by Type (2021-2032)
  5. 8.2 North America Ertapenem Injection Market Size by Application
  6. 8.2.1 North America Ertapenem Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Ertapenem Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Ertapenem Injection Price by Application (2021-2032)
  9. 8.3 North America Ertapenem Injection Market Size by Country
  10. 8.3.1 North America Ertapenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ertapenem Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ertapenem Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Ertapenem Injection Market Size by Type
  2. 9.1.1 Europe Ertapenem Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ertapenem Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Ertapenem Injection Price by Type (2021-2032)
  5. 9.2 Europe Ertapenem Injection Market Size by Application
  6. 9.2.1 Europe Ertapenem Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ertapenem Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Ertapenem Injection Price by Application (2021-2032)
  9. 9.3 Europe Ertapenem Injection Market Size by Country
  10. 9.3.1 Europe Ertapenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ertapenem Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ertapenem Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Ertapenem Injection Market Size by Type
  2. 10.1.1 China Ertapenem Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Ertapenem Injection Sales by Type (2021-2032)
  4. 10.1.3 China Ertapenem Injection Price by Type (2021-2032)
  5. 10.2 China Ertapenem Injection Market Size by Application
  6. 10.2.1 China Ertapenem Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Ertapenem Injection Sales by Application (2021-2032)
  8. 10.2.3 China Ertapenem Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ertapenem Injection Market Size by Type
  2. 11.1.1 Asia Ertapenem Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ertapenem Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Ertapenem Injection Price by Type (2021-2032)
  5. 11.2 Asia Ertapenem Injection Market Size by Application
  6. 11.2.1 Asia Ertapenem Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ertapenem Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Ertapenem Injection Price by Application (2021-2032)
  9. 11.3 Asia Ertapenem Injection Market Size by Country
  10. 11.3.1 Asia Ertapenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ertapenem Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ertapenem Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ertapenem Injection Market Size by Type
  2. 12.1.1 SAMEA Ertapenem Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ertapenem Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ertapenem Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Ertapenem Injection Market Size by Application
  6. 12.2.1 SAMEA Ertapenem Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ertapenem Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ertapenem Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Ertapenem Injection Market Size by Country
  10. 12.3.1 SAMEA Ertapenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ertapenem Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ertapenem Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ertapenem Injection Value Chain Analysis
  2. 13.1.1 Ertapenem Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ertapenem Injection Production Mode & Process
  6. 13.2 Ertapenem Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ertapenem Injection Distributors
  9. 13.2.3 Ertapenem Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst